M
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A8.7 KBMAP Pharmaceuticals, Inc.Feb 7, 4:23 PM ET·0000053417-14-000101
- SC 13G/A8.2 KBMAP Pharmaceuticals, Inc.Feb 7, 2:07 PM ET·0001137774-14-000090
- SC 13D/A277.6 KBMAP Pharmaceuticals, Inc.Mar 4, 6:38 PM ET·0000807249-13-000060
- 8-K134.7 KBMAP Pharmaceuticals, Inc.Mar 1, 5:22 PM ET·0001193125-13-088005
- SC TO-T/A102.3 KBMAP Pharmaceuticals, Inc.Mar 1, 3:53 PM ET·0001193125-13-087599
- SC 13G/A8.1 KBMAP Pharmaceuticals, Inc.Feb 14, 2:06 PM ET·0000315066-13-002642
- SC 13G11.8 KBMAP Pharmaceuticals, Inc.Feb 14, 1:48 PM ET·0001172661-13-000571
- SC 13G27.0 KBMAP Pharmaceuticals, Inc.Feb 12, 1:13 PM ET·0000080255-13-000452
- SC 13G/A8.9 KBMAP Pharmaceuticals, Inc.Feb 11, 5:19 PM ET·0001137774-13-000067
- SC 13G/A8.7 KBMAP Pharmaceuticals, Inc.Feb 11, 2:58 PM ET·0000053417-13-000008
Insiders
10- ARMER THOMAS ADirector, CSO, Director
- Borland ScottSVP, Neurology Franchise
- CHAI CHRISTOPHER YChief Financial Officer
- ELMS STEVEDirector
- Freund John GordonDirector
- Friedman Charlene AVP President, Gen Counsel &Sec
- GIANAKAKOS ANASTASIOSSVP, Cor & Business Dev
- GOLDFISCHER CARLDirector
- HENWOOD GERALDINEDirector
- KELLERMAN DONALD JSVP,Clinical Dev & Med Affairs
Tickers
No tickers on record
Addresses
business
2400 BAYSHORE PARKWAY, SUITE 200
MOUNTAIN VIEW, CA, 94043
mailing
2400 BAYSHORE PARKWAY, SUITE 200
MOUNTAIN VIEW, CA, 94043